Partnering to Respond to a Possible Nuclear Threat
Published: | Updated:
Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Bob Mulroy
Advertisement
Bob Mulroy is director and chief executive officer of Partner Therapeutics
Articles by Bob Mulroy
Advertisement
Latest Updated Articles
Partnering to Respond to a Possible Nuclear ThreatPublished: May 25th 2022 | Updated: July 25th 2023
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Leading in the Psychedelic Space: Q&A with Tarek Rabah
4
Pharmaceutical Executive Daily: FDA Approves Hernexeos
5